Hinova Pharmaceuticals, Inc. Class ASSE: 688302

Announcement on the Voluntary Disclosure of the Inclusion of Deutenzalutamide Soft Capsules in the 2025 National Medical Insurance Drug Catalog

· Issued by Hinova Pharmaceuticals, Inc. Class A via Shanghai Stock Exchange
Announcement on the Voluntary Disclosure of the Inclusion of Deutenzalutamide Soft Capsules in the 2025 National Medical Insurance Drug Catalog

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis